243 related articles for article (PubMed ID: 21517805)
1. Guidelines for supportive care in multiple myeloma 2011.
Snowden JA; Ahmedzai SH; Ashcroft J; D'Sa S; Littlewood T; Low E; Lucraft H; Maclean R; Feyler S; Pratt G; Bird JM;
Br J Haematol; 2011 Jul; 154(1):76-103. PubMed ID: 21517805
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma.
Infante Cossío P; Cabezas Macián A; Pérez Ceballos JL; Palomino Nicas J; Gutiérrez Pérez JL
Med Oral Patol Oral Cir Bucal; 2008 Jan; 13(1):E52-7. PubMed ID: 18167482
[TBL] [Abstract][Full Text] [Related]
3. Management of complications in multiple myeloma.
Terpos E; Cibeira MT; Blade J; Ludwig H
Semin Hematol; 2009 Apr; 46(2):176-89. PubMed ID: 19389501
[TBL] [Abstract][Full Text] [Related]
4. Supportive care in multiple myeloma.
Ludwig H; Zojer N
Best Pract Res Clin Haematol; 2007 Dec; 20(4):817-35. PubMed ID: 18070721
[TBL] [Abstract][Full Text] [Related]
5. [Multiple myeloma].
Abe M
Nihon Rinsho; 2009 May; 67(5):991-5. PubMed ID: 19432122
[TBL] [Abstract][Full Text] [Related]
6. Osteonecrosis of the jaw related to the use of bisphosphonates.
Van den Wyngaert T; Huizing MT; Vermorken JB
Curr Opin Oncol; 2007 Jul; 19(4):315-22. PubMed ID: 17545793
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonate-induced osteonecrosis of the jaw: long-term outcomes.
Katz J; George T; Sandow P; Machado M; Dickerson L; Moreb JS
J Support Oncol; 2009; 7(1):9-10. PubMed ID: 19278171
[No Abstract] [Full Text] [Related]
8. The incidence of jaw osteonecrosis in multiple myeloma patients treated with bisphosphonates.
Kraj M; Pogłód R; Maj S; Owczarska K
Acta Pol Pharm; 2006; 63(5):450-2. PubMed ID: 17357613
[No Abstract] [Full Text] [Related]
9. Bisphosphonates and osteonecrosis of the jaws: science and rationale.
Gutta R; Louis PJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):186-93. PubMed ID: 17448709
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.
Ruggiero SL; Fantasia J; Carlson E
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Oct; 102(4):433-41. PubMed ID: 16997108
[No Abstract] [Full Text] [Related]
11. Why osteonecrosis of the jaw after bisphosphonates treatment is more frequent in multiple myeloma than in solid tumors.
Delibasi T; Altundag K; Kanlioglu Y
J Oral Maxillofac Surg; 2006 Jun; 64(6):995-6. PubMed ID: 16713825
[No Abstract] [Full Text] [Related]
12. [Bisphosphonates for myeloma patients].
Miwa A
Nihon Rinsho; 2007 Dec; 65(12):2315-37. PubMed ID: 18069279
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.
Marx RE; Sawatari Y; Fortin M; Broumand V
J Oral Maxillofac Surg; 2005 Nov; 63(11):1567-75. PubMed ID: 16243172
[TBL] [Abstract][Full Text] [Related]
14. Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment.
Dickinson M; Prince HM; Kirsa S; Zannettino A; Gibbs SD; Mileshkin L; O'Grady J; Seymour JF; Szer J; Horvath N; Joshua DE
Intern Med J; 2009 May; 39(5):304-16. PubMed ID: 19220531
[TBL] [Abstract][Full Text] [Related]
15. Supportive care in multiple myeloma.
Chanan-Khan A; Miller KC
Clin Lymphoma Myeloma; 2006 Jul; 7(1):42-50. PubMed ID: 16879769
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonate-related osteonecrosis: genetic and acquired risk factors.
Sarasquete ME; González M; San Miguel JF; García-Sanz R
Oral Dis; 2009 Sep; 15(6):382-7. PubMed ID: 19413677
[TBL] [Abstract][Full Text] [Related]
17. Osteonecrosis and bisphosphonates in oral and maxillofacial surgery.
Chaudhry AN; Ruggiero SL
Oral Maxillofac Surg Clin North Am; 2007 May; 19(2):199-206, vi. PubMed ID: 18088878
[TBL] [Abstract][Full Text] [Related]
18. Bisphosphonate-associated osteonecrosis of the jaw: conclusions based on an analysis of case series.
Landesberg R; Wilson T; Grbic JT
Dent Today; 2006 Aug; 25(8):52, 54-7. PubMed ID: 16925161
[TBL] [Abstract][Full Text] [Related]
19. Maxilla osseus sequestre and oral exposure: effects of the treatment of multiple myeloma with bisphosphonates.
Lobato JV; Rodrigues JM; Cavaleiro MV; Lobato JM; Xavier L; Santos JD; Maurício AC
Acta Med Port; 2007; 20(2):185-92. PubMed ID: 17868526
[TBL] [Abstract][Full Text] [Related]
20. Medical management update: multiple myeloma.
Stoopler ET; Vogl DT; Stadtmauer EA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 May; 103(5):599-609. PubMed ID: 17291793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
